340 B Drug Pricing Program

Richard P. Church is a National Law Review Go-To Thought Leader for his ongoing coverage and analysis of healthcare compliance issues, the regulation of drug prices and the 340 B Drug Reimbursement program. Mr. Church’s extensive experience with state and federal fraud compliance and Medicare/Medicaid reimbursement issues really shows when he interprets the implications of executive orders and the flurry of last minute healthcare regulatory changes from the outgoing Trump administration.